Setareh Seyedkazemi serves as Executive at Adverum Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Setareh Seyedkazemi has executed 9 insider transactions totaling $32.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved transacting 88,332 shares valued at $0.
Setareh Seyedkazemi currently holds 88,332 shares of Adverum Biotechnologies, Inc. (ADVM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Setareh Seyedkazemi has been a net buyer of ADVM stock. They have purchased $16.8K and sold $15.9K worth of shares.
Setareh Seyedkazemi's most recent insider trade was on Dec 9, 2025, when they sold 88,332 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 9, 2025 | ADVM | $0 | Award | 85,000 | $N/A | Discretionary |
| Dec 9, 2025 | ADVM | $0 | Tender | 54,874 | $N/A | Discretionary |
| Sep 15, 2023 | ADVM | $202 | Sale | 130 | $1.55 | Discretionary |
| Sep 15, 2023 | ADVM | $9.2K | Sale | 6,071 | $1.52 | Discretionary |
| Sep 19, 2022 | ADVM | $6.5K | Sale | 6,058 | $1.07 | Discretionary |
| Sep 14, 2022 | ADVM | $0 | Award | 33,333 | $N/A | Discretionary |
| May 23, 2022 | ADVM | $16.8K | Purchase | 20,000 | $0.84 | Discretionary |